Constance CareWAR:CCR 32 Median PS Value is zł0.00 as of Jun. 27, 2026. GuruFocus rates WAR:CCR with a GF Score™ of 32/100 and a GF Value™ of zł0.15 (Significantly Overvalued). Among 264 Healthcare Providers & Services companies, Constance Care ranks worse than 378787.5% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2026-06-27), Constance Care's share price is zł6.00. Constance Care's Median PS Value is zł0.00. Therefore, Constance Care's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Constance Care's Median PS Value or its related term are showing as below:
WAR:CCR's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.7 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Constance Care (WAR:CCR) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Constance Care's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
6.00
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Constance Care Median PS Value Related Terms
Constance Care Median PS Value Historical Data
* Premium members only.
The historical data trend for Constance Care's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:CCR vs HCA, UHS, CHE: Median PS Value Comparison
For the Medical Care Facilities subindustry, Constance Care's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Constance Care Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Constance Care's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Constance Care's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
Constance Care's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Constance Care (WAR:CCR) has a Median PS Value of zł0.00 as of Jun. 27, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Constance Care and its competitors. According to the industry distribution chart, Constance Care ranks #999999 out of 264 companies in the Healthcare Providers & Services industry.
Is Constance Care's Median PS Value too high?
Constance Care's current Median PS Value is zł0.00. Based on the distribution chart, Constance Care ranks #999999 out of 264 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Constance Care has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constance Care's Median PS Value compare to HCA and UHS?
According to the Healthcare Providers & Services industry distribution chart, Constance Care ranks #999999 out of 264 companies for Median PS Value. This places Constance Care in the lower half of its industry. The industry median Median PS Value is 0.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.70, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Constance Care and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Constance Care's current Median PS Value is zł0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constance Care stock overvalued right now?
Based on GuruFocus' analysis, Constance Care (WAR:CCR) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.15, compared to a current price of zł6.00 — trading 3900% above its estimated fair value. The current Median PS Value is zł0.00. Constance Care's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Constance Care (WAR:CCR), the current Median PS Value is zł0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Constance Care (WAR:CCR) Overvalued in 2026?
Based on GuruFocus' analysis, Constance Care stock appears to be overvalued.
The current stock price of zł6.00 is trading 3900% above its estimated GF Value™ of zł0.15.
GuruFocus considers Constance Care to be Significantly Overvalued.
Key valuation signals for WAR:CCR:
Median PS Value: zł0.00
GF Value™: zł0.15 vs. price of zł6.00 (3900% above fair value)
No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
32GF Score
Get the complete analysis for WAR:CCR
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CCR has been successfully added to your 
